Middle East Pharmaceutical Industries 過去の業績
過去 基準チェック /66
Middle East Pharmaceutical Industries has been growing earnings at an average annual rate of 1.4%, while the Pharmaceuticals industry saw earnings growing at 10.3% annually. Revenues have been growing at an average rate of 15.3% per year. Middle East Pharmaceutical Industries's return on equity is 23.6%, and it has net margins of 21.7%.
主要情報
1.4%
収益成長率
1.4%
EPS成長率
| Pharmaceuticals 業界の成長 | 12.4% |
| 収益成長率 | 15.3% |
| 株主資本利益率 | 23.6% |
| ネット・マージン | 21.7% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
収支内訳
Middle East Pharmaceutical Industries の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 367 | 79 | 141 | 0 |
| 31 Mar 24 | 359 | 76 | 133 | 0 |
| 31 Dec 23 | 338 | 66 | 129 | 0 |
| 30 Sep 23 | 328 | 63 | 126 | 0 |
| 30 Jun 23 | 318 | 59 | 122 | 0 |
| 31 Mar 23 | 291 | 50 | 117 | 0 |
| 31 Dec 22 | 303 | 59 | 114 | 0 |
| 31 Dec 21 | 287 | 66 | 98 | 0 |
| 31 Dec 20 | 302 | 73 | 95 | 0 |
質の高い収益: 4016 has high quality earnings.
利益率の向上: 4016's current net profit margins (21.7%) are higher than last year (18.6%).
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 4016's earnings have grown by 1.4% per year over the past 5 years.
成長の加速: 4016's earnings growth over the past year (33.9%) exceeds its 5-year average (1.4% per year).
収益対業界: 4016 earnings growth over the past year (33.9%) exceeded the Pharmaceuticals industry 7.1%.
株主資本利益率
高いROE: 4016's Return on Equity (23.6%) is considered high.